We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Image Fusion PET, CT and 3D-ultrasound Examinations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00302094
Recruitment Status : Completed
First Posted : March 13, 2006
Last Update Posted : December 3, 2012
Information provided by (Responsible Party):
Caroline Ewertsen, Rigshospitalet, Denmark

Brief Summary:

CT-examinations are used in computer programs which are used in the planning of external radiation of cancers in the anal canal. In CT the structures of the anal canal are hardly visible. 3D-ultrasound examinations offer a better visualisation of normal and pathological structures of the anal canal. The description of the tumour made from the 3D-ultrasound examination is used in the planning of the external radiation.

PET-CT is used to visualise tumour activity also in lymp nodes. The hypothesis of the study is that image fusion of PET, CT and 3D-ultrasound will offer better visualisation of tumour and hereby more accurate diagnostics and treatment.

Condition or disease
Anal Cancer

Study Type : Observational
Actual Enrollment : 10 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Image Fusion PET, CT and 3D-ultrasound Examinations in Treatment of Anal Cancer
Study Start Date : June 2006
Primary Completion Date : April 2009
Study Completion Date : April 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. Program to fuse 3D ultrasound and PET/CT data [ Time Frame: april 2009 ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with anal cancer

Inclusion Criteria:

  • Histologically verified cancer of the anal canal

Exclusion Criteria:

  • Pregnancy
  • Unability to cooperate to radiation therapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00302094

Clinic of Radiology, Section of Ultrasound, Rigshospitalet
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Study Director: Michael B Nielsen, Dmsci, phd. Rigshospitalet, Denmark
Principal Investigator: Caroline Ewertsen, MD Rigshospitalet, Denmark

Responsible Party: Caroline Ewertsen, MD, PhD, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT00302094     History of Changes
Other Study ID Numbers: (KF) 11-107/03
First Posted: March 13, 2006    Key Record Dates
Last Update Posted: December 3, 2012
Last Verified: November 2012

Additional relevant MeSH terms:
Anus Neoplasms
Rectal Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Anus Diseases
Rectal Diseases